Daniel Devine & Company Has Lowered Procter & Gamble (PG) Stake as Stock Declined; American Research & Management Lifted Its Holding in Gilead Sciences (GILD) as Stock Declined

February 15, 2018 - By Vivian Park

American Research & Management increased its stake in Gilead Sciences Inc (GILD) by 32.9% based on its latest 2017Q3 regulatory filing with the SEC. American Research & Management bought 4,845 shares as the company’s stock declined 8.05% while stock markets rallied. The institutional investor held 19,570 shares of the health care company at the end of 2017Q3, valued at $1.59M, up from 14,725 at the end of the previous reported quarter. American Research & Management who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $106.54B market cap company. The stock decreased 0.32% or $0.26 during the last trading session, reaching $81.56. About 3.52M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since February 15, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Daniel Devine & Company decreased its stake in Procter & Gamble (PG) by 54.69% based on its latest 2017Q3 regulatory filing with the SEC. Daniel Devine & Company sold 4,387 shares as the company’s stock declined 5.32% while stock markets rallied. The institutional investor held 3,635 shares of the package goods and cosmetics company at the end of 2017Q3, valued at $331,000, down from 8,022 at the end of the previous reported quarter. Daniel Devine & Company who had been investing in Procter & Gamble for a number of months, seems to be less bullish one the $206.42 billion market cap company. The stock increased 1.49% or $1.2 during the last trading session, reaching $81.88. About 4.00M shares traded. The Procter & Gamble Company (NYSE:PG) has risen 7.54% since February 15, 2017 and is uptrending. It has underperformed by 9.16% the S&P500.

Among 24 analysts covering Proctor & Gamble (NYSE:PG), 12 have Buy rating, 0 Sell and 12 Hold. Therefore 50% are positive. Proctor & Gamble had 77 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of The Procter & Gamble Company (NYSE:PG) has “Buy” rating given on Tuesday, September 8 by Suntrust Robinson. Stifel Nicolaus maintained the stock with “Hold” rating in Thursday, July 27 report. The stock of The Procter & Gamble Company (NYSE:PG) earned “Buy” rating by Johnson Rice on Friday, August 26. Credit Suisse downgraded the stock to “Outperform” rating in Thursday, July 30 report. The firm has “Buy” rating by Jefferies given on Wednesday, November 15. The firm has “Market Perform” rating by Wells Fargo given on Tuesday, November 15. The firm earned “Buy” rating on Wednesday, October 12 by Argus Research. As per Tuesday, October 3, the company rating was maintained by Jefferies. The firm has “Neutral” rating by B. Riley & Co given on Monday, October 26. The rating was upgraded by UBS to “Buy” on Thursday, July 14.

Since August 15, 2017, it had 0 buys, and 3 selling transactions for $3.16 million activity. $321,221 worth of stock was sold by FergusonMchugh MaryLynn on Tuesday, August 15. Shares for $154,168 were sold by Keith R. Alexandra on Tuesday, August 15. Majoras Deborah P sold $401,642 worth of stock. $266,273 worth of The Procter & Gamble Company (NYSE:PG) was sold by Skoufalos Ioannis on Tuesday, August 15. The insider Pritchard Marc S. sold 3,684 shares worth $339,077. The insider Matthew Price sold $115,695.

Investors sentiment decreased to 0.82 in Q3 2017. Its down 0.12, from 0.94 in 2017Q2. It turned negative, as 51 investors sold PG shares while 765 reduced holdings. 110 funds opened positions while 558 raised stakes. 1.50 billion shares or 1.10% more from 1.48 billion shares in 2017Q2 were reported. Yacktman Asset Ltd Partnership holds 13.54% of its portfolio in The Procter & Gamble Company (NYSE:PG) for 15.40 million shares. Ashford Capital Mngmt reported 0.04% stake. Cornerstone Advsr has invested 0.89% of its portfolio in The Procter & Gamble Company (NYSE:PG). Cincinnati Fincl Corporation invested in 49,900 shares or 0.21% of the stock. Halbert Hargrove Russell Limited Company holds 5,070 shares. Mercer Capital Advisers reported 57,367 shares or 3.87% of all its holdings. Birinyi Assocs holds 0.53% or 12,259 shares. Profit Ltd Liability has invested 0.31% in The Procter & Gamble Company (NYSE:PG). American Registered Invest Advisor holds 0.88% or 19,290 shares. Aperio Gru Limited Liability Com holds 1.65 million shares or 0.85% of its portfolio. Hilton Cap Ltd Liability Com has 0.04% invested in The Procter & Gamble Company (NYSE:PG). Bouchey Group invested in 2,916 shares. Telemus Ltd Liability Corporation owns 13,741 shares. M&R Management Inc invested 0.81% in The Procter & Gamble Company (NYSE:PG). Opus has invested 1.04% in The Procter & Gamble Company (NYSE:PG).

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 124 analyst reports since July 29, 2015 according to SRatingsIntel. The stock has “Buy” rating by William Blair on Wednesday, June 14. Mizuho initiated the stock with “Buy” rating in Tuesday, November 8 report. The rating was maintained by BMO Capital Markets with “Hold” on Monday, August 28. Bank of America maintained it with “Neutral” rating and $86 target in Wednesday, October 4 report. On Wednesday, January 20 the stock rating was initiated by Credit Suisse with “Outperform”. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Buy” rating by Argus Research on Thursday, August 31. The stock has “Buy” rating by RBC Capital Markets on Wednesday, October 4. The rating was initiated by Gabelli with “Buy” on Wednesday, June 1. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Outperform” rating given on Wednesday, February 3 by Credit Suisse. On Wednesday, February 7 the stock rating was maintained by Bank of America with “Neutral”.

Since August 30, 2017, it had 0 buys, and 13 sales for $51.09 million activity. Meyers James R sold $4.99 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Thursday, August 31. The insider MARTIN JOHN C sold $4.18M. The insider Washington Robin L sold $4.40M.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>